Aurora Cannabis (ACB) EBIT Margin (2017 - 2025)
Aurora Cannabis (ACB) reported EBIT Margin of 20.77% for Q4 2025, down 2102.0% year-over-year from 1.04% in Q4 2024, and up 378.37% quarter-over-quarter from 4.34% in Q3 2025.
Aurora Cannabis (ACB) EBIT Margin (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of EBIT Margin data on file, last reported at 20.77% in Q4 2025.
- EBIT Margin for Q4 2025 came in at 20.77%, down 2102.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.36% (down 988.0% YoY), and the FY2025 annual result was 1.44%, up 1817.0% from the prior year.
- EBIT Margin grew to 20.77% in Q4 2025 per ACB's latest filing, from 4.34% in the prior quarter.
- Over five years, EBIT Margin peaked at 41.79% in Q4 2024 and troughed at 8769.49% in Q3 2021.
- A 5-year average of 530.88% and a median of 26.94% in 2023 frame the typical range for EBIT Margin.
- The sharpest annual moves came in 2021 and 2022: EBIT Margin sank 872630 bps in 2021, then surged 866708 bps in 2022.
- A 5-year view of EBIT Margin shows it stood at 80.73% in 2021, then slumped by 36 bps to 109.59% in 2022, then jumped by 75 bps to 27.33% in 2023, then jumped by 253 bps to 41.79% in 2024, then sank by 50 bps to 20.77% in 2025.
- Business Quant data shows ACB's EBIT Margin at 20.77% in Q4 2025, 4.34% in Q3 2025, and 1.54% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -122.23% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -12.88% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 46.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.77% |
| Sep 30, 2025 | 4.34% |
| Jun 30, 2025 | -1.54% |
| Mar 31, 2025 | -26.54% |
| Dec 31, 2024 | 41.79% |
| Sep 30, 2024 | -2.95% |
| Jun 30, 2024 | -1.18% |
| Mar 31, 2024 | -3.35% |
| Dec 31, 2023 | -27.33% |
| Sep 30, 2023 | -17.15% |
| Dec 31, 2022 | -109.59% |
| Sep 30, 2022 | -102.41% |
| Jun 30, 2022 | -119.89% |
| Mar 31, 2022 | -95.07% |
| Dec 31, 2021 | -80.73% |
| Sep 30, 2021 | -8,769.49% |
| Jun 30, 2021 | -60.69% |
| Mar 31, 2021 | -204.76% |
| Dec 31, 2020 | -52.74% |
| Sep 30, 2020 | -43.19% |